Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.

Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.

Item
http://www.wikidata.org/entity/Q37503975
Why industry propaganda and political interference cannot disguise the inevitable role played by human exposure to aluminum in neurodegenerative diseases, including Alzheimer's diseaseVirus-Like Particle (VLP) Plus Microcrystalline Tyrosine (MCT) Adjuvants Enhance Vaccine Efficacy Improving T and B Cell Immunogenicity and Protection against Plasmodium berghei/vivax.Behavioral abnormalities in female mice following administration of aluminum adjuvants and the human papillomavirus (HPV) vaccine Gardasil.Aluminium in Allergies and Allergen immunotherapy.Potential of nanoparticles for allergen-specific immunotherapy - use of silica nanoparticles as vaccination platform.Nanoparticle based-immunotherapy against allergy.Are there negative CNS impacts of aluminum adjuvants used in vaccines and immunotherapy?Adjuvants in micro- to nanoscale: current state and future direction.Allergen immunotherapy in allergic rhinitis: current use and future trends.Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.Microcrystalline Tyrosine (MCT®): A Depot Adjuvant in Licensed Allergy Immunotherapy Offers New Opportunities in Malaria.Cutaneous vaccination with coated microneedles prevents development of airway allergy.Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.
P2860

Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.

Item
http://www.wikidata.org/entity/Q37503975
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@en
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@nl
type
label
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@en
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@nl
prefLabel
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@en
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@nl
P1433
P1476
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Aluminium adjuvants and adverse events in sub-cutaneous allergy immunotherapy.
@en
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932